Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Why Viatris (VTRS) Is Buying Oyster Point (OYST)
08:53pm, Monday, 07'th Nov 2022
Viatris (VTRS) announced it is buying Oyster Point Pharma (OYST). This is why.
Viatris Inc. (VTRS) Q3 2022 Earnings Call Transcript
02:41pm, Monday, 07'th Nov 2022
Viatris Inc. (NASDAQ:VTRS ) Q3 2022 Results Conference Call November 7, 2022 8:30 AM ET Company Participants Bill Szablewski - Head of Global Capital Markets Robert Coury - Executive Chairman Michael
Viatris (VTRS) Q3 Earnings Beat, Revenues Miss Estimates
12:50pm, Monday, 07'th Nov 2022
Viatris (VTRS) beats on Q3 earnings but misses sales estimates as fluctuations in foreign exchange rates continue to impact results. The company reaffirms guidance.
Why Viatris Stock Is Jumping Today
12:41pm, Monday, 07'th Nov 2022
Investors are applauding a key step in Viatris' plans to return to growth.
Why Viatris Shares Are Soaring Higher - Viatris (NASDAQ:VTRS)
11:04am, Monday, 07'th Nov 2022
Viatris Inc (NASDAQ: VTRS) shares are trading higher by 16.80% to $11.33 Monday morning after the company announced it will acquire Oyster Point Pharma. What Happened?
Viatris (VTRS) Stock Pops 17% on Acquisition News
10:51am, Monday, 07'th Nov 2022
Viatris (NASDAQ: VTRS ) issued a press release today with a slew of good news. For one thing, Viatris is acquiring two different businesses.
Viatris (VTRS) Q3 Earnings Beat Estimates
09:50am, Monday, 07'th Nov 2022
Viatris (VTRS) delivered earnings and revenue surprises of 4.88% and 1.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Vanguard Health Care Fund Exits Viatris, Plugs Into GSK in 3rd Quarter
06:12pm, Friday, 04'th Nov 2022
The Vanguard Health Care Fund (Trades, Portfolio) disclosed in a regulatory filing that its top trades during the third quarter included the closure of its positions in Viatris Inc. ( VTRS , Financial
Viatris Asset Disposals Make The Value Case For Their Branded Portfolio
08:21am, Sunday, 30'th Oct 2022
In the latest quarter, ignoring the quite severe effects of the dollar's appreciation, Viatris' brands performed well. But even for biosimilars, Viatris is proving portfolio value in the sale of that
PITTSBURGH , Oct. 24, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will announce financial results for the third quarter of 2022 on Monday, November 7, 2022. Executive Chairman Robert J.
3 Healthcare Stocks That Are Too Cheap to Ignore
09:45am, Saturday, 22'nd Oct 2022
They all offer attractive dividends, too.
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
08:45am, Saturday, 22'nd Oct 2022
Procrastination could be problematic with these three bargain stocks.
Should I invest in Viatris shares after the current dip?
08:21am, Saturday, 08'th Oct 2022
Viatris Inc. (NASDAQ: VTRS) shares have weakened from $10.20 to $8.42 since September 12, 2022, and the current price stands at $8.74. The U.S. stock market remains under pressure, and going forward,
October 2022 Stock Considerations
03:54pm, Monday, 03'rd Oct 2022
The silver lining amid the market collapse is that every new dollar put to work today in dividend stocks comes with an automatic higher yield when compared to just a few weeks ago. First up, I'm think
Take These Broken Wings And Learn To Fly Again Viatris
06:30pm, Sunday, 25'th Sep 2022
We were cautious on Viatris as we felt the three headwinds we anticipated would lead to a guidance cut. We were partially correct on that outcome, but the stock still went lower despite holding the fr
